Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-27

Clinical Trial Update: Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules. [Phase 1]

View source ↗

Summary

A Phase 1 study assessing bioequivalence of Orfadin 20 mg to Orfadin 10 mg capsules in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orfadin (nitisinone)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2014-10-27